Cargando…
Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1
Oncocytic thyroid cancer is characterized by the aberrant accumulation of abnormal mitochondria in the cytoplasm and a defect in oxidative phosphorylation. We performed metabolomics analysis to compare metabolic reprogramming among the oncocytic and non-oncocytic thyroid cancer cell lines XTC.UC1 an...
Autores principales: | Kurashige, Tomomi, Shimamura, Mika, Hamada, Koichiro, Matsuse, Michiko, Mitsutake, Norisato, Nagayama, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813134/ https://www.ncbi.nlm.nih.gov/pubmed/36599897 http://dx.doi.org/10.1038/s41598-023-27461-2 |
Ejemplares similares
-
Cancer Stem Cells in the Thyroid
por: Nagayama, Yuji, et al.
Publicado: (2016) -
Causative role for defective expression of mitochondria‐eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors
por: Mussazhanova, Zhanna, et al.
Publicado: (2020) -
MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF(V600E)-positive thyroid cancer
por: Hamada, Koichiro, et al.
Publicado: (2022) -
Reevaluation of the Effect of Iodine on Thyroid Cell Survival and Function Using PCCL3 and Nthy-ori 3-1 Cells
por: Kurashige, Tomomi, et al.
Publicado: (2020) -
Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer
por: Nagayama, Yuji, et al.
Publicado: (2022)